Dr. Katharine Bar, MD

• Infectious Disease Medicine

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Iowa

  Medical School, 2002

• Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+T cell reservoir, 2022-12-19

• Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome, 2012-10-30

• Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes, 2016-07-20

• CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after ART interruption, 2020-03-16

• A Community Call to Action to Prioritize Inclusion and Enrollment of Women in HIV Cure-Related Research, 2022-09-02

• New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention, and Cure, 2021-05-10

• Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response, 2021-11-25

• Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART, 2021-12-08

• Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee, 2017-06-02

• HIV-1 and Hepatitis C Virus Selection Bottleneck in Chinese People Who Inject Drugs, 2018-01-28

• Efficientex vivoexpansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates, 2023-05-03

• Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques, 2023-07-03

• Determinants of hospital outcomes for patients with COVID-19 in the University of Pennsylvania Health System, 2022-05-19

• HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies, 2022-04-11

• Heightened resistance to type 1 interferons characterizes HIV-1 at transmission and following treatment interruption, 2021-01-13

• Recommendations for measuring HIV reservoir size in cure-directed clinical trials., 2020-09-07

• Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques, 2021-04-12

• Recapitulation of HIV-1 Env-Antibody Coevolution in Macaques Leading to Neutralization Breadth, 2020-11-19

• Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques, 2023-08-10

• Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model Goswami et al., 2019-09-05

• Functional Antibodies in COVID-19 Convalescent Plasma, 2021-03-11

• Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes, 2016-10-15

• Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+T Cells Obregon-Perko et al., 2020-12-22

• Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1, 2022-07-30

• Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape, 2012-05-31